Status:
COMPLETED
SARS-CoV-2 Pre-exposure Prophylaxis With Ivermectin Retrospective Cohort Study
Lead Sponsor:
Grupo Rescue S.A.S República Dominicana
Conditions:
Covid19
Eligibility:
All Genders
18+ years
Brief Summary
This observational study, a multicenter retrospective cohort database study, carried out in two medical centers, Centro Medico Bournigal (CMBO) in Puerto Plata and Centro Medico Punta Cana (CMPC) in P...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Active workers from Centro Medico Bournigal (CMBO) and Centro Medico Punta Cana (CMPC) during the study.
- Exclusion Criteria
- Workers with positive Covid-19 RT-PCR prior to the start of the study
- Those that did not take the first dose of Ivermectin the first week at the start of the study
- Those that did not complied with at least 2 out of 4 weekly doses
- Those that had greater than 14 days difference in days between two intakes Ivermectin
Exclusion
Key Trial Info
Start Date :
June 29 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 10 2021
Estimated Enrollment :
713 Patients enrolled
Trial Details
Trial ID
NCT04832945
Start Date
June 29 2020
End Date
April 10 2021
Last Update
April 13 2021
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Centro Medico Bournigal
Puerto Plata, Dominican Republic, 57000
2
Centro Médico Punta Cana
Punta Cana, Dominican Republic, 23000